<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD><TITLE>TNS 8-K 06-09-09</TITLE>
<META content=06/12/2009 name=date>
</HEAD>
<BODY
style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 12pt; FONT-FAMILY: Times New Roman">
<P style="FONT-SIZE: 13.5pt; MARGIN: 0px; LINE-HEIGHT: 15.5pt"
align=center><B>UNITED STATES</B></P>
<P style="FONT-SIZE: 13.5pt; MARGIN: 0px; LINE-HEIGHT: 15.5pt"
align=center><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P style="MARGIN: 0px" align=center><B>Washington D.C., 20549 </B></P>
<P style="FONT-SIZE: 7.5pt; MARGIN: 0px">&nbsp;</P>
<P style="FONT-SIZE: 18pt; MARGIN: 0px; LINE-HEIGHT: 20pt" align=center><B>Form
8-K</B></P>
<P style="FONT-SIZE: 7.5pt; MARGIN: 0px">&nbsp;</P>
<P style="FONT-SIZE: 13.5pt; MARGIN: 0px; LINE-HEIGHT: 15.5pt"
align=center><B>Current Report</B></P>
<P style="MARGIN: 0px" align=center><BR></P>
<P style="FONT-SIZE: 13.5pt; MARGIN: 0px; LINE-HEIGHT: 15.5pt"
align=center><B>Pursuant to Section 13 or 15(d) of the Securities Exchange Act
of 1934 </B></P>
<P style="FONT-SIZE: 7.5pt; MARGIN: 0px">&nbsp;</P>
<P style="FONT-SIZE: 12pt; MARGIN: 0px; LINE-HEIGHT: 14pt" align=center><B>Date
Of Report (Date Of Earliest Event Reported):&nbsp;&nbsp;06/09/2009</B></P>
<P style="MARGIN: 0px" align=center><BR></P>
<P style="MARGIN: 0px" align=center><IMG height=108 alt=[tns8k060909apg001.jpg]
src="tns8k060909apg001.jpg" width=222 align=middle></P>
<P style="MARGIN: 0px" align=center><BR></P>
<P style="FONT-SIZE: 18pt; MARGIN: 0px; LINE-HEIGHT: 20pt"
align=center><B><U>Total Nutraceutical Solutions, Inc. </U></B></P>
<P style="MARGIN: 0px" align=center><B>(Exact Name of Registrant as Specified in
its Charter)</B></P>
<P style="FONT-SIZE: 7.5pt; MARGIN: 0px">&nbsp;</P>
<P style="FONT-SIZE: 12pt; MARGIN: 0px; LINE-HEIGHT: 14pt"
align=center><B>Commission File Number:&nbsp; <U>000-52864</U></B></P>
<P style="FONT-SIZE: 7.5pt; MARGIN: 0px">&nbsp;</P>
<TABLE style="FONT-SIZE: 10pt" cellSpacing=0 align=center>
<TR style="FONT-SIZE: 0px" height=0>
<TD width=314></TD>
<TD width=22></TD>
<TD width=302></TD></TR>
<TR>
<TD vAlign=bottom width=314>
<P style="FONT-SIZE: 12pt; MARGIN: 0px; LINE-HEIGHT: 14pt"
align=center><B><U>NEVADA</U></B></P></TD>
<TD vAlign=bottom width=22>
<P
style="FONT-SIZE: 7.5pt; MARGIN: 0px; LINE-HEIGHT: 14pt">&nbsp;&nbsp;<FONT
style="FONT-SIZE: 12pt">&nbsp;</FONT></P></TD>
<TD vAlign=bottom width=302>
<P style="FONT-SIZE: 12pt; MARGIN: 0px; LINE-HEIGHT: 14pt"
align=center><B><U>26-0561199</U></B></P></TD></TR>
<TR>
<TD vAlign=top width=314>
<P style="MARGIN: 0px; TEXT-INDENT: -16px" align=center><B>(State or Other
Jurisdiction of</B></P></TD>
<TD vAlign=bottom width=22>
<P
style="FONT-SIZE: 7.5pt; MARGIN: 0px; LINE-HEIGHT: 14pt">&nbsp;&nbsp;<FONT
style="FONT-SIZE: 12pt">&nbsp;</FONT></P></TD>
<TD vAlign=bottom width=302>
<P style="MARGIN: 0px" align=center><B>(I.R.S. Employer</B></P></TD></TR>
<TR>
<TD vAlign=top width=314>
<P style="MARGIN: 0px; TEXT-INDENT: -16px" align=center><B>Incorporation
or Organization)</B></P></TD>
<TD vAlign=bottom width=22>
<P
style="FONT-SIZE: 7.5pt; MARGIN: 0px; LINE-HEIGHT: 14pt">&nbsp;&nbsp;<FONT
style="FONT-SIZE: 12pt">&nbsp;</FONT></P></TD>
<TD vAlign=bottom width=302>
<P style="MARGIN: 0px" align=center><B>Identification
No.)</B></P></TD></TR></TABLE>
<P style="FONT-SIZE: 7.5pt; MARGIN: 0px">&nbsp;</P>
<P style="FONT-SIZE: 12pt; MARGIN: 0px; LINE-HEIGHT: 14pt"
align=center><B><U>2811 Reidville Road, Suite 23, Spartanburg, SC &nbsp;29301
</U></B></P>
<P style="MARGIN: 0px; LINE-HEIGHT: normal" align=center><B>(Address of
Principal Executive Offices, Including Zip Code)</B><FONT
style="FONT-SIZE: 12pt"> </FONT></P>
<P style="FONT-SIZE: 7.5pt; MARGIN: 0px">&nbsp;</P>
<P style="FONT-SIZE: 12pt; MARGIN: 0px; LINE-HEIGHT: 14pt"
align=center><B><U>(864) 316-2909</U></B></P>
<P style="MARGIN: 0px" align=center><B>(Registrant&#146;s Telephone Number, Including
Area Code) </B></P>
<P style="MARGIN: 0px" align=center><BR></P>
<P style="MARGIN: 0px" align=center>_________________</P>
<P style="MARGIN: 0px" align=center><B>(Former name or former address, if
changed since last report) </B></P>
<P style="MARGIN: 0px">&nbsp;&nbsp;</P>
<P style="MARGIN: 0px"><BR></P>
<P style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 16px"><B>Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing
obligation of the registrant under any of the following provisions:</B></P>
<P style="MARGIN: 0px"><B>[ &nbsp;]&nbsp;&nbsp; Written communications pursuant
to Rule 425 under the Securities Act (17 CFR
230.425)<BR><BR>[&nbsp;&nbsp;]&nbsp;&nbsp; Soliciting material pursuant to Rule
14a-12 under the Exchange Act(17CFR240.14a-12)<BR><BR>[&nbsp;&nbsp;]&nbsp;&nbsp;
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act(17CFR240.14d-2(b))<BR><BR>[&nbsp;&nbsp;]&nbsp;&nbsp; Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange
Act(17CFR240.13e-4(c)) </B></P>
<P style="MARGIN: 0px"><BR></P>
<P style="MARGIN: 0px"><BR><BR></P>
<HR style="MARGIN-TOP: 9px; MARGIN-BOTTOM: 9px" noShade SIZE=1>
<P style="PAGE-BREAK-BEFORE: always; MARGIN: 0px"><BR></P>
<TABLE style="FONT-SIZE: 10pt" cellSpacing=0>
<TR style="FONT-SIZE: 0px" height=0>
<TD width=100></TD>
<TD width=571></TD></TR>
<TR>
<TD vAlign=top width=100>
<P style="PADDING-LEFT: 9px; MARGIN: 0px"><B>Item&nbsp;1.01.</B></P></TD>
<TD vAlign=top width=571>
<P style="PADDING-LEFT: 9px; MARGIN: 0px"><B>Entry into a Material
Definitive Agreement.</B></P></TD></TR></TABLE>
<P style="PADDING-RIGHT: 48px; MARGIN: 0px">&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P style="MARGIN: 0px; TEXT-INDENT: 32px" align=justify>On June 9, 2009, Total
Nutraceutical Solutions, Inc. (the &#147;Company&#148;) entered into definitive agreements
relating to the private placement of $409,500 of its securities through the sale
of 819,000 units at $.50 per unit, consisting of 1,638,000 shares of its
restricted common stock and 819,000 &#147;A&#148; warrants and 819,000 &#147;B&#148; warrants to
nine accredited investors.&nbsp; The Purchasers in the private placement were
Nancy Cowgill, Annette Perini, Michael Erickson, Horacio Bellofiore, Mark Wolf,
Allen Peters, David Braunstein, Paul Gerald and Lori Hyland.</P>
<P style="MARGIN: 0px" align=justify><BR></P>
<P style="MARGIN: 0px" align=justify><BR></P>
<P style="MARGIN: 0px"><BR></P><A name=FIS_SALE_OF_EQUITY></A>
<TABLE style="FONT-SIZE: 10pt" cellSpacing=0>
<TR style="FONT-SIZE: 0px" height=0>
<TD width=100></TD>
<TD width=571></TD></TR>
<TR>
<TD vAlign=top width=100>
<P style="PADDING-LEFT: 9px; MARGIN: 0px"><B>Item&nbsp;3.02.</B></P></TD>
<TD vAlign=top width=571>
<P style="PADDING-LEFT: 9px; MARGIN: 0px"><B>Unregistered Sales of
Securities.</B></P></TD></TR></TABLE>
<P style="MARGIN: 0px"><BR></P>
<P style="MARGIN: 0px; TEXT-INDENT: 48px" align=justify>On June 9, 2009 Total
Nutraceutical Solutions, Inc. (the &#147;Company&#148;) closed a private offering and
issued 819,000 Units at $.50 per unit to nine accredited investor for $409,500.
&nbsp;The Units consisted of two (2) shares of its par value $.001 unregistered
common stock, One (1) &#147;A&#148; Stock Purchase Warrant to Purchase One Additional
Share of Common Stock at $.75 Per Share and One (1) &#147;B&#148; Stock Purchase Warrant
to Purchase One Additional Share of Common Stock at $1.00 Per Share for a Period
of Three Years. &nbsp;Total Nutraceutical Solutions, Inc. sold these shares and
warrants to further capitalize the Company in order to execute its business
plan.</P>
<P style="MARGIN: 0px" align=justify><BR></P>
<P style="MARGIN: 0px; TEXT-INDENT: 48px" align=justify>The Company is relying
on the exemption from registration provided by Section 4(2) and Rule 506 of
Regulation D under the Securities Act of 1933, as amended (&#147;Regulation D&#148;), for
sales to &#147;accredited investors&#148; (as such term is defined in Rule 501 of
Regulation D). &nbsp;The purchaser has represented to the Company that they are
an &#147;accredited investor.&#148; &nbsp;We believed that Section 4(2) was available
because the offer and sale did not involve a public offering and there was not
general solicitation or general advertising involved in the offer or sale.</P>
<P style="MARGIN: 0px"><BR></P>
<TABLE style="FONT-SIZE: 10pt" cellSpacing=0>
<TR style="FONT-SIZE: 0px" height=0>
<TD width=100></TD>
<TD width=571></TD></TR>
<TR>
<TD vAlign=top width=100>
<P style="PADDING-LEFT: 9px; MARGIN: 0px"><B>Item 9.01.</B></P></TD>
<TD vAlign=top width=571>
<P style="PADDING-LEFT: 9px; MARGIN: 0px"><B>Exhibits. &nbsp;Financial
Statements and Exhibits</B></P></TD></TR></TABLE>
<P style="PADDING-RIGHT: 48px; MARGIN: 0px">&nbsp;&nbsp;</P>
<TABLE style="FONT-SIZE: 10pt" cellSpacing=0>
<TR style="FONT-SIZE: 0px" height=0>
<TD width=45></TD>
<TD width=46></TD>
<TD width=580></TD></TR>
<TR>
<TD width=45>
<P style="PADDING-LEFT: 9px; MARGIN: 0px">&nbsp;&nbsp;</P></TD>
<TD vAlign=top width=46>
<P style="PADDING-LEFT: 9px; MARGIN: 0px">(c)</P></TD>
<TD vAlign=top width=580>
<P
style="PADDING-LEFT: 9px; MARGIN: 0px"><U>Exhibits</U></P></TD></TR></TABLE>
<P style="PADDING-RIGHT: 48px; MARGIN: 0px">&nbsp;&nbsp;<A
name=FIS_UNIDENTIFIED_TABLE></A></P>
<TABLE style="FONT-SIZE: 10pt" cellSpacing=0>
<TR style="FONT-SIZE: 0px" height=0>
<TD width=55></TD>
<TD width=47></TD>
<TD width=606></TD></TR>
<TR>
<TD width=55>
<P>&nbsp;</P></TD>
<TD vAlign=top width=47>
<P style="MARGIN: 0px" align=right>10.1</P></TD>
<TD width=606>
<P style="PADDING-LEFT: 9px; MARGIN: 0px">&nbsp;Form of Subscription
Agreement and other related documents entered into by the Company on
&nbsp;June 9, 2009.</P></TD></TR>
<TR>
<TD vAlign=top width=55>
<P>&nbsp;</P></TD>
<TD vAlign=top width=47>
<P>&nbsp;</P></TD>
<TD vAlign=bottom width=606>
<P>&nbsp;</P></TD></TR></TABLE>
<P style="PADDING-RIGHT: 48px; MARGIN: 0px">&nbsp;&nbsp;</P>
<P style="MARGIN: 0px"><BR></P>
<P style="MARGIN: 0px"><BR></P>
<P style="MARGIN: 0px" align=center><B>SIGNATURES</B></P>
<P style="MARGIN: 0px"><BR></P>
<P style="MARGIN: 0px; TEXT-INDENT: 48px" align=justify>Pursuant to the
requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.</P>
<P style="MARGIN: 0px"><BR></P>
<P style="MARGIN: 0px">Dated: &nbsp;June 9, 2009</P>
<P style="MARGIN: 0px"><BR></P>
<P style="MARGIN: 0px; TEXT-INDENT: 336px">Total Nutraceutical Solutions,
Inc.</P>
<P style="MARGIN: 0px; TEXT-INDENT: 336px">(Registrant)</P>
<P style="MARGIN: 0px"><BR></P>
<P style="MARGIN-TOP: 0px; MARGIN-BOTTOM: -16px; TEXT-INDENT: 336px">By: </P>
<P style="MARGIN: 0px; TEXT-INDENT: 384px"><U>/s/ &nbsp;Marvin S. Hausman, M.D.,
CEO</U></P>
<P style="MARGIN: 0px; TEXT-INDENT: 384px">Marvin S. Hausman</P>
<P style="MARGIN: 0px; TEXT-INDENT: 384px">CEO/Director</P>
<P
style="MARGIN: 0px"><BR><BR></P></BODY>
<!-- EDGAR Validation Code: F8C99721 -->
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "tns8k060909apg.htm", "description": "TNS, INC. 8-K 06-09-09", "secsgml_size_bytes": 10990}]
{"company-data": {"conformed-name": "Total Nutraceutical Solutions, Inc.", "cik": "0001408299", "assigned-sic": "7363", "irs-number": "260561199", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-52864", "film-number": "09890554"}, "business-address": {"street1": "2811 REIDVILLE RD.", "street2": "SUITE 23", "city": "SPARTANBURG", "state": "SC", "zip": "29301", "phone": "864-316-2909"}, "mail-address": {"street1": "2811 REIDVILLE RD.", "street2": "SUITE 23", "city": "SPARTANBURG", "state": "SC", "zip": "29301"}, "former-company": [{"former-conformed-name": "Total Nutraceutical Solutions", "date-changed": "20081024"}, {"former-conformed-name": "Generic Marketing Services, Inc.", "date-changed": "20070730"}]}
TNS 8-K 06-09-09
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C., 20549
Form
8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act
of 1934
Date
Of Report (Date Of Earliest Event Reported):  06/09/2009
Total Nutraceutical Solutions, Inc.
(Exact Name of Registrant as Specified in
its Charter)
Commission File Number:
000-52864
NEVADA
26-0561199
(State or Other
Jurisdiction of
(I.R.S. Employer
Incorporation
or Organization)
Identification
No.)
2811 Reidville Road, Suite 23, Spartanburg, SC  29301
(Address of
Principal Executive Offices, Including Zip Code)
(864) 316-2909
(Registrant's Telephone Number, Including
Area Code)
_________________
(Former name or former address, if
changed since last report)
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing
obligation of the registrant under any of the following provisions:
[  ]   Written communications pursuant
to Rule 425 under the Securities Act (17 CFR
230.425)
[  ]   Soliciting material pursuant to Rule
14a-12 under the Exchange Act(17CFR240.14a-12)
[  ]  
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act(17CFR240.14d-2(b))
[  ]   Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange
Act(17CFR240.13e-4(c))
Item 1.01.
Entry into a Material
Definitive Agreement.
On June 9, 2009, Total
Nutraceutical Solutions, Inc. (the "Company") entered into definitive agreements
relating to the private placement of $409,500 of its securities through the sale
of 819,000 units at $.50 per unit, consisting of 1,638,000 shares of its
restricted common stock and 819,000 "A" warrants and 819,000 "B" warrants to
nine accredited investors.  The Purchasers in the private placement were
Nancy Cowgill, Annette Perini, Michael Erickson, Horacio Bellofiore, Mark Wolf,
Allen Peters, David Braunstein, Paul Gerald and Lori Hyland.
Item 3.02.
Unregistered Sales of
Securities.
On June 9, 2009 Total
Nutraceutical Solutions, Inc. (the "Company") closed a private offering and
issued 819,000 Units at $.50 per unit to nine accredited investor for $409,500.
 The Units consisted of two (2) shares of its par value $.001 unregistered
common stock, One (1) "A" Stock Purchase Warrant to Purchase One Additional
Share of Common Stock at $.75 Per Share and One (1) "B" Stock Purchase Warrant
to Purchase One Additional Share of Common Stock at $1.00 Per Share for a Period
of Three Years.  Total Nutraceutical Solutions, Inc. sold these shares and
warrants to further capitalize the Company in order to execute its business
plan.
The Company is relying
on the exemption from registration provided by Section 4(2) and Rule 506 of
Regulation D under the Securities Act of 1933, as amended ("Regulation D"), for
sales to "accredited investors" (as such term is defined in Rule 501 of
Regulation D).  The purchaser has represented to the Company that they are
an "accredited investor."  We believed that Section 4(2) was available
because the offer and sale did not involve a public offering and there was not
general solicitation or general advertising involved in the offer or sale.
Item 9.01.
Exhibits.  Financial
Statements and Exhibits
(c)
Exhibits
10.1
Form of Subscription
Agreement and other related documents entered into by the Company on
 June 9, 2009.
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
Dated:  June 9, 2009
Total Nutraceutical Solutions,
Inc.
(Registrant)
By:
/s/  Marvin S. Hausman, M.D.,
CEO
Marvin S. Hausman
CEO/Director